XBRANE BIOPHARMA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.208 SEK | -2.58% |
|
-11.49% | -97.92% |
| 04-22 | Transcript : Xbrane Biopharma AB - Special Call | |
| 03-18 | Xbrane Biopharma AB(OM:XBRANE) dropped from S&P Global BMI Index | CI |
Evolution of the average Target Price on Xbrane Biopharma AB
Price target over the last 5 years
History of analyst recommendation changes
61ef762c87e1ec7fa889d24e79754.PFQ-leMrRkojiu_TY8kdGWJ4FYsHlo9AUeGU2AQu21o.dRhZ0bdsfyVlvduLC41EUARMWfxxzOwNFaOs7XFrrgoPJ3TR1x4vJmrEgA~478c92a5670c182186aa4deff07fe8fe
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.208
SEK
Average target price
0.625
SEK
Spread / Average Target
+200.48%
High Price Target
0.65
SEK
Spread / Highest target
+212.50%
Low Price Target
0.6
SEK
Spread / Lowest Target
+188.46%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C+
EPS Revisions
- Stock Market
- Equities
- XBRANE Stock
- Consensus Xbrane Biopharma AB
